CAMBRIDGE, MA – 28 December 2007: Virtify relocated their Headquarters from its old location of 210 Broadway Street, Suite 101, Cambridge MA 02139 to its new and current location of 55 Cambridge Parkway, Suite 410, Cambridge, MA 02142. This move is welcomed especially to fit in with the company’s expansion plan. This location in “Cambridge is one of the leading centers of the biotech and life sciences industry in the world. Our new home in the heart of this exciting mix of industry, academia, and research will help us service our customers better and faster. Critical decisions regarding our products and solutions can be made quickly when our engineering team meets with our client in front of a whiteboard and works through the issues. This location makes that possible.” said Satish Tadikonda, President of Virtify.
The new office is adjacent to the River Charles and to the Charlesgate Yacht Club. The Cambridgeside Galleria Mall and the Museum of Science are in walking distance from the new Virtify Headquarters.
About Virtify
Virtify is a global company, with headquarters in Cambridge, MA and other international locations in India, Philippines and Bulgaria. We use cutting edge web-based technologies and global delivery capabilities to develop and implement innovative software products and solutions for the Life Sciences industry.
One of our strengths is our deep domain knowledge and demonstrated leadership in emerging global standards. Virtify is one of the first companies to introduce a pure web-based Structured Product Labeling (SPL) solution for managing the entire life cycle of labels. Virtify was the first to submit a SPL demo to the Food and Drug Administration (FDA) and the first company to submit a Regulated Product Submission (RPS) drug device and combination drug submission to the FDA. The first RPS Viewer was also introduced by Virtify we were the first to submit an Electronic Common Technical Documents (eCTD) drug and device submission to the FDA. In addition, we have recently been the first to submit messages in emerging standards such as eStability and ICSR. Such leadership on standards has enabled us to work closely with clients in effectively planning for emerging standards while addressing current mandates and standards for clinical and regulatory submissions.
Virtify’s clients include several pharmaceutical, and biotechnology companies, and its projects have spanned the R&D lifecycle, from discovery through commercialization.. For additional information about Virtify, please visit
http://www.virtify.com.